RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+60.85%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$5.96B
AUM Growth
+$5.96B
(+44%)
Cap. Flow
+$508M
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
47.57%
Holding
116
New
26
Increased
35
Reduced
12
Closed
14
Top Buys
| 1 |
Arvinas
ARVN
|
$152M |
| 2 |
Globus Medical
GMED
|
$107M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$99M |
| 4 |
Pulmonx
LUNG
|
$74.8M |
| 5 |
Illumina
ILMN
|
$69.1M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$128M |
| 2 |
Baxter International
BAX
|
$86.6M |
| 3 |
Incyte
INCY
|
$30M |
| 4 |
Q32 Bio
QTTB
|
$26.9M |
| 5 |
VXRT
Vaxart
VXRT
|
$23.4M |
Sector Composition
| 1 | Healthcare | 94% |
| 2 | Financials | 0.18% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Pulmonx
LUNG
$67.6M
| $74.8M | 1.26% |
+1,129,600
| New | +$74.8M |
|
27
Protagonist Therapeutics
PTGX
$3.62B
| $73.6M | 1.23% |
3,650,069
+241,108
| +7% | +$4.86M |
|
28
C4 Therapeutics
CCCC
$182M
| $68.7M | 1.15% |
+2,149,228
| New | +$68.7M |
|
29
Tandem Diabetes Care
TNDM
$834M
| $63.2M | 1.06% |
660,982
+57,501
| +10% | +$5.5M |
|
30
Celldex Therapeutics
CLDX
$1.57B
| $60M | 1.01% |
3,422,855
+302,718
| +10% | +$5.3M |
|
31
Kura Oncology
KURA
$732M
| $55.6M | 0.93% |
+1,701,781
| New | +$55.6M |
|
|
TBIO
32
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $54.9M | 0.92% |
2,978,427
-766,859
| -20% | -$14.1M |
|
|
NSTG
33
DELISTED
NanoString Technologies, Inc.
NSTG
| $53.8M | 0.9% |
804,029
-143,105
| -15% | -$9.57M |
|
34
Castle Biosciences
CSTL
$673M
| $53.7M | 0.9% |
799,009
+55,367
| +7% | +$3.72M |
|
35
Relmada Therapeutics
RLMD
$48.8M
| $48.5M | 0.81% |
1,512,673
+1,336
| +0.1% | +$42.8K |
|
|
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $46.5M | 0.78% |
6,722,624
+59,185
| +0.9% | +$409K |
|
|
FPRX
37
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $42.8M | 0.72% |
+2,515,788
| New | +$42.8M |
|
38
Cytokinetics
CYTK
$5.98B
| $41.3M | 0.69% |
2,000,000
| – | – |
|
|
AGEN
39
Agenus
AGEN
$136M
| $40.9M | 0.69% |
12,864,677
| – | – |
|
|
OYST
40
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $36.2M | 0.61% |
1,925,594
+1,701
| +0.1% | +$32K |
|
|
AVDL
41
Avadel Pharmaceuticals
AVDL
$1.42B
| $36M | 0.6% |
5,387,513
+20,808
| +0.4% | +$139K |
|
|
ITOS
42
DELISTED
iTeos Therapeutics
ITOS
| $36M | 0.6% |
1,074,166
+171,311
| +19% | +$5.74M |
|
43
Outset Medical
OM
$245M
| $33.3M | 0.56% |
585,074
+180,074
| +44% | +$10.2M |
|
|
TRIL
44
DELISTED
Trillium Therapeutics Inc.
TRIL
| $31.9M | 0.53% |
2,165,197
+4,397
| +0.2% | +$64.7K |
|
45
PMV Pharmaceuticals
PMVP
$82.1M
| $30.8M | 0.52% |
500,882
+882
| +0.2% | +$54.3K |
|
46
Curis
CRIS
$21.5M
| $30.5M | 0.51% |
+3,727,360
| New | +$30.5M |
|
|
CELL
47
DELISTED
PhenomeX Inc. Common Stock
CELL
| $29M | 0.49% |
324,734
+24,396
| +8% | +$2.18M |
|
48
Milestone Pharmaceuticals
MIST
$151M
| $28.9M | 0.49% |
4,315,102
| – | – |
|
49
MacroGenics
MGNX
$121M
| $28.7M | 0.48% |
1,256,409
+1,110
| +0.1% | +$25.4K |
|
50
IDEAYA Biosciences
IDYA
$2.26B
| $25.9M | 0.43% |
+1,846,843
| New | +$25.9M |
|